Advertisement
Research Article

Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

  • Kristin Rising,

    Affiliation: School of Medicine, University of California San Francisco, San Francisco, California, United States of America

    ¤ Current address: Department of Internal Medicine, Boston Medical Center, Boston, Massachusetts, United States of America

    X
  • Peter Bacchetti,

    Affiliation: Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

    X
  • Lisa Bero mail

    To whom correspondence should be addressed. E-mail: berol@pharmacy.ucsf.edu

    Affiliation: Clinical Pharmacy and Health Policy, University of California San Francisco, San Francisco, California, United States of America

    X
  • Published: November 25, 2008
  • DOI: 10.1371/journal.pmed.0050217

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Correction: Reporting Bias in Drug Trials Submitted to the Food and Drug Administration: Review of Publication and Presentation

Kristin Rising, Peter Bacchetti, Lisa Bero
Correction | published 27 Jan 2009 | PLOS Medicine
doi:10.1371/journal.pmed.1000017

Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results

An-Wen Chan
Perspective | published 25 Nov 2008 | PLOS Medicine
doi:10.1371/journal.pmed.0050230

Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature Analysis

Kirby Lee, Peter Bacchetti, Ida Sim
Research Article | published 23 Sep 2008 | PLOS Medicine
doi:10.1371/journal.pmed.0050191